Preliminary phase II results of oxaliplatin, 5-FU, and leucovorin in advanced biliary tract cancer.

被引：0

作者：

Lee, S.

Kim, H.

Kim, S.

Kim, C.

Bae, S.

Lee, K.

Yun, J.

Hong, D.

Park, H.

机构：

[1] Soonchunhyang Univ Hosp, Seoul, South Korea

[2] Soonchunhyang Univ, Bucheon Hosp, Puchon, South Korea

[3] Soonchunhyang Univ, Cheonan Hosp, Cheonan, South Korea

[4] Soonchunhyang Univ Cheonan, Cheonan, South Korea

[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.e14507

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e14507

引用

下载

页数：1

共 50 条

[31] Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study
Katja Ott
Andreas Sendler
Karen Becker
Hans-Joachim Dittler
Hermann Helmberger
Raimonde Busch
Christian Kollmannsberger
J. Rüdiger Siewert
Ulrich Fink
Gastric Cancer, 2003, 6 (3) : 159 - 167
[32] EXIBIT:: An international multicenter phase II trial of gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer.
André, T.
Reyes-Vidal, J. M.
Fartoux, L.
Ross, P.
Leslie, M.
Rosmorduc, O.
Clemens, M. R.
Louvet, C.
Perez, N.
Scheithauer, W.
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 211S - 211S
[33] Final results of first line treatment with 5-fluorouracil (5-FU), leucovorin (LV) and oxaliplatin (L-OHP) in advanced colorectal cancer (ACC): A multicenter phase II study.
Souglakos, J
Kouroussis, C
Ziras, N
Malamos, N
Potamianou, A
Mavroudis, D
Kakolyris, S
Androulakis, N
Vardakis, N
Georgoulias, V
ANNALS OF ONCOLOGY, 2000, 11 : 49 - 49
[34] Multicenter phase II study of docetaxel and oxaliplatin combination in patients with locally advanced or metastatic biliary tract cancer.
Song, Eun-Kee
Han, Hye-Suk
Lee, Ki Hyeong
Lee, Kyu Taek
Bae, Sang Byung
Kim, Han Jo
Kim, Samyong
Yun, Hwan Jung
Cho, Sang Hoe
Shim, Hyun-Jeong
Yhim, Ho-Young
Leo, Na-Ri
Joon, So Yoon
Yim, Chang-Yeoi
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[35] Phase Ib study of gemcitabine and oxaliplatin with erlotinib in patients with advanced biliary tract cancer.
Ciombor, Kristen Keon
Cardin, Dana Backlund
Chan, Emily
McClanahan, Pamela
Fan, Kang-Hsien
Flynn, Jayme
Young, Ruth T.
DeMers, April
Smith, Stephen James
Berlin, Jordan
Goff, Laura Williams
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[36] A Multicenter Phase-II Study of 5-FU, Leucovorin and Oxaliplatin (FOLFOX6) in Patients with Pretreated Metastatic Colorectal Cancer
Kato, Ken
Inaba, Yoshitaka
Tsuji, Yasushi
Esaki, Taito
Yoshioka, Akira
Mizunuma, Nobuyuki
Mizuno, Toshiro
Kusaba, Hitoshi
Fujii, Hirohumi
Muro, Kei
Shimada, Yasuhiro
Shirao, Kuniaki
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (01) : 63 - 68
[37] Oxaliplatin added to simplified bimonthly low-dose leucovorin and 5-FU for pretreated advanced colorectal cancer is effective and not affected by different previous 5-FU regimens
Hsieh, RK
Chao, TY
Chen, WS
Yang, TS
Chen, LT
Chen, PM
Liu, JH
CANCER INVESTIGATION, 2004, 22 (02) : 171 - 179
[38] Oxaliplatin in combination with 5-fluorouracil (5-FU) and leucovorin (LV) in previously treated patients with advanced metastatic gastric cancer
Cavanna, L
Zaniboni, A
Artioli, F
Lazzaro, A
Rizzi, A
Mazzocchi, M
Anselmi, E
Bidin, L
Palladino, M
Rodinò, C
ANNALS OF ONCOLOGY, 2005, 16 : 323 - 323
[39] Randomized phase II study of combined infusional leucovorin sodium (LVNa) and 5-FU versus the sequential administration of leucovorin calcium (LVCa) followed by 5-FU with irinotecan or oxaliplatin in patients (pts) with metastatic colorectal cancer (mCRC)
Bleiberg, H.
Vandebroek, A.
Deleu, I.
Vergauwe, P.
Kalantari, H. Rezael
D'Haens, G.
Paesmans, M.
Peeters, M.
Efira, A.
Humblet, Y.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[40] UFT/leucovorin vs 5-FU/leucovorin in colon cancer
Smith, RE
Lembersky, BC
Wieand, HS
Colangelo, L
Mamounas, EP
ONCOLOGY-NEW YORK, 2000, 14 (10): : 24 - 27

← 1 2 3 4 5 →